Partnership Opportunities

Showcase Your Solutions to a Room Full of Personalized Cancer Vaccine Experts

With momentum building across mRNA, peptide, viral vector, DNA, and dendritic cell platforms, PCV developers face mounting pressure to deliver scalable, regulatory-ready, and patient-specific therapies. Without the right partners, personalized vaccine development is impossible.

The field is actively seeking focused discussions on selecting the right CDMOs, delivery platforms, analytics, and regulatory advisors - making the 2nd Annual Personalized Cancer Vaccines Summit your unmissable opportunity to position your solutions as must-haves.

Returning to Boston this November, the summit brings together 80+ PCV leaders to tackle manufacturing bottlenecks, scale, bioinformatics, trial design complexity, and regulatory and clinical translation challenges. With a star-studded, high-caliber faculty including Moderna, Merck, Genentech, Dana-Farber, Geneos, and more, you'll gain direct access to decision-makers across CMC, clinical, regulatory, and translational roles to forge long-lasting, successful collaborations.

If you offer:

On-demand or modular GMP platforms

For low-volume, high-mix PCV manufacturing

Neoantigen discovery and verification tools

To support target selection and reduce trial failure

Next-gen immune monitoring or biomarker analytics

For validating clinical response

Adjuvant systems, LNPs, or delivery tech

Optimized for personalized dosing and tumor targeting

AI-powered trial ops and workflow automation

To compress timelines and improve scalability

Regulatory consulting

For platform-based and batch-specific submissions

This is your opportunity to stand out in front of hyper-relevant buyers who are actively refining their platforms, building next-gen PCV programs, and accelerating safe, effective and affordable PCVs to patients.

Why Partner With The Summit?

• Access Unfiltered Market Insights
Hear directly from senior leaders at top biotechs on critical gaps in PCV development - from GMP scale to clinical translation - so you can align your solution where it’s most needed.

• Showcase Targeted Solutions
Present your offerings to key decision-makers in PCV programs actively seeking vendors for materials, analytics, manufacturing, and regulatory support.

• Connect at the Right Time
Engage buyers facing urgent challenges through sessions focused on real bottlenecks, supported by structured networking for high-impact deals.

Audience Composition

Graph 1 (4)
Company Types Graph

Get in Touch

For more information about partnership options, contact sponsor@hansonwade.com.

Want to get involved?

Speak with our partnerships director today to find out what opportunities best suit you.

Anika

Anika Johal
Partnerships Director